Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PLx Pharma Inc.
  6. Financials
    PLXP   US72942A1079

PLX PHARMA INC.

(PLXP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 13,440,076,8408--
Entreprise Value (EV)1 13,440,076,8408408408
P/E ratio 15,3x-1,14x-3,17x-14,0x-25,1x-65,8x
Yield ------
Capitalization / Revenue 17,8x70,7x2 524x71,2x15,4x6,94x
EV / Revenue 17,8x70,7x2 524x71,2x15,4x6,94x
EV / EBITDA -1 243 308x-2 847 728x----
Price to Book ------
Nbr of stocks (in thousands) 8 7449 15213 91222 981--
Reference price (USD) 1,534,375,5218,418,418,4
Announcement Date 03/08/201903/13/202003/12/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 0,750,570,035,7326,558,9
EBITDA -10,8-14,0----
Operating profit (EBIT)1 -11,0-14,2-13,5-23,2-18,5-8,60
Operating Margin -1 455%-2 512%-44 230%-404%-69,8%-14,6%
Pre-Tax Profit (EBT)1 0,90-20,5-15,2-25,3-10,6-1,60
Net income1 0,90-34,3-16,9-27,3-18,0-8,40
Net margin 119%-6 058%-55 695%-476%-67,8%-14,3%
EPS2 0,10-3,84-1,74-1,32-0,73-0,28
Dividend per Share ------
Announcement Date 03/08/201903/13/202003/12/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 ----2,373,37
EBITDA ------
Operating profit (EBIT)1 -3,19-3,69-3,60-5,10-6,45-8,00
Operating Margin -----273%-238%
Pre-Tax Profit (EBT)1 -3,13-7,98-11,5-4,00-4,00-5,80
Net income1 -3,63-8,49-11,9-4,83-6,35-7,90
Net margin -----268%-235%
EPS2 -0,40-0,87-0,73-0,22-0,27-0,33
Dividend per Share ------
Announcement Date 11/13/202003/12/202105/14/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow ------
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex ------
Capex / Sales ------
Announcement Date 03/08/201903/13/202003/12/2021---
1 USD in Million
Key data
Capitalization (USD) 408 380 224
Net sales (USD) 30 430
Number of employees 10
Sales / Employee (USD) 3 043
Free-Float 81,8%
Free-Float capitalization (USD) 333 951 949
Avg. Exchange 20 sessions (USD) 18 754 730
Average Daily Capital Traded 4,59%
EPS & Dividend